New Drug Application submitted to the U.S. Food and Drug Administration for CARDAMYST ™, the conditionally approved brand name for etripamil nasal spray, for patients with PSVT Positive Phase 2 data ...

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT ...

Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p 0.0001) ...

Atrial fibrillation, or AFib, is the most common type of arrhythmia in adults. A heart arrhythmia is when your heartbeat has an abnormal rate or rhythm. This can mean it beats too slowly, too quickly, ...